Passion, Plants, and Phase III: Devonian Health Group Is on a Mission to Disrupt Inflammation Therapy
While the industry might be dominated by synthetic compounds, billion-dollar VC funds, and long, uncertain development timelines, Devonian Health Group Inc. is proving there is another way. As a publicly traded company, under the leadership of its founder and CEO, Dr. André P. Boulet, Devonian has quietly advanced multi-target drug candidates and a cutting-edge cosmeceutical line, backed not by institutional investors but by a network of Canadian family offices made up of dentists, physicians, engineers, and entrepreneurs.
Boulet's journey to this unconventional success story reads like a masterclass in risk, reinvention, and scientific conviction. "I'm a venture capitalist in my heart," Boulet says. "But I'm also a scientist. When I saw the anti-inflammatory results of this botanical extract technology from a university agriculture project, I knew this had real potential. So, I followed my instinct and took the risk."
With a PhD in physiology-endocrinology, postdoctoral training in biochemistry and biophysics, and experience leading cardiovascular clinical research programs, Boulet's transition from academia to venture capital was swift. After climbing the pharmaceutical ladder and managing funds in Montreal, he exited his partnership and launched what would become Devonian Health Group in 2015.
At its core, Devonian is a clinical-stage pharmaceutical company focused on autoimmune and inflammatory conditions, with its lead drug candidate, Thykamine ™, poised to enter Phase III clinical trials for atopic dermatitis and soon pediatric eczema.
"Traditional pharma was built on the 'silver bullet,' one target, one mechanism," Boulet explains. "But now science is evolving. We're moving toward therapies that modulate multiple pathways. That's exactly what Thykamine does without shutting down important immune functions like TNF-alpha. That's why our efficacy is high, but side effects are minimal."
What sets Devonian apart isn't just its marquee drug but the platform behind it. The company's patented SUPREX™ technology allows for water-based extraction, purification, and stabilization of Active Botanical Ingredients (ABIs) from plants and algae. These complexes modulate inflammation at the genetic level across multiple diseases, offering a broad pipeline of possibilities.
To date, Thykamine™ has demonstrated strong results in its Phase II trial. Both gastrointestinal (ulcerative colitis) and dermatological (eczema) models have shown significant symptom relief and safety comparable to placebo.
Remarkably, all this has been achieved without traditional VC backing. Boulet credits this to his deep network of entrepreneurial allies and his belief in business-first partnerships. "We've raised funds to advance to Phase III, built an extraction and production facility, and kept the company debt-free," he says.
While the pharmaceutical arm garners headlines, Devonian's cosmeceutical division is equally ambitious. Operating under the Purgenesis™ brand, the company has developed a premium line of anti-aging creams containing its patented botanical ingredient R-Spinasome®, a photosynthetic cell extract with dynamic antioxidant properties.
What makes Purgenesis™ unusual in the beauty space is its clinical rigor. Devonian has conducted peer-reviewed, pharma-grade clinical trials on the entire product line, something virtually unheard of in the cosmeceutical industry. "We've scientifically proven a reduction in wrinkles," says Boulet. "Not just pretty pictures, but peer-reviewed, published data. We're the only ones doing cosmeceuticals the pharma way."
With day, night, and eye creams already developed and a professional-grade serum in the pipeline, Devonian is currently seeking commercial partners to bring Purgenesis™ to a global market hungry for results-backed skincare.
Perhaps the most unusual aspect of Devonian's success is how personal it all feels. There are no Silicon Valley investors or hedge fund suits behind the curtain, just a network of entrepreneurs who believe in the mission. "Working with family offices is stimulating," Boulet says. "You get input from pharmacists, dentists, and industrialists. We face challenges together, and we have fun doing it."
The company's headquarters in Québec includes a full-scale extraction and production facility, providing complete traceability from seed to pill. This vertical integration helps with both cutting costs, yes, but also ensuring product consistency.
For Boulet, the journey has been one of passion and perseverance. "In life, there's always a risk," he reflects. "But if you surround yourself with the right people and believe in what you're building, that risk becomes your fuel. That's what Devonian is about: science, instinct, and community."
As the company readies for Phase III trials in both pharmaceuticals and final-stage commercialization of its skincare line, Devonian Health Group stands as a testament to the power of conviction and the potential of plants to reshape the future of medicine.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Int'l Business Times
19 hours ago
- Int'l Business Times
The Financial Partners Founder On How Smart Business Leaders Are Building Tax-Free Wealth Using Other People's Money
Most people think of life insurance as a cost, a necessary protection policy filed away in a drawer. But what if it could be one of the most powerful tax-free wealth-building tools available? That's the question, Michael (Mike) Smith, Managing Partner and founder of The Financial Partners Group (TFP), believes more business owners and high earners should be asking. "Premium financing life insurance has long been the playbook of the ultra-wealthy," Smith explains. "But the game has changed. We're now helping executives, entrepreneurs, and even professional athletes use this strategy to create tax-free income and preserve wealth for generations. And no, it's not as risky as most people assume." Premium financing is a strategy where a client borrows money from a third-party lender to fund a life insurance policy, usually an indexed universal life (IUL) or similar cash-value vehicle. Instead of tying up capital in hefty annual premiums, the client retains control of their cash while the policy accumulates value over time. According to Smith, this approach flips the traditional insurance conversation on its head. "We're not talking about paying $100 a month to get a death benefit. We're talking about using institutional strategies, used by billionaires, banks, and major corporations, to create a tax-advantaged retirement income and long-term wealth preservation vehicle." In short, the client gets access to market upside without downside risk, IRS-compliant tax-free income through policy loans or withdrawals, and significant death benefit protection for their heirs. Smith further shares that there are minimal upfront out-of-pocket costs. And the biggest kicker is it's built on borrowed money, what he calls "one of the most efficient ways to use leverage in the financial world." Historically, premium financing was reserved for the ultra-wealthy. But Smith says today's savvy professionals, especially those under 55 with strong income, are increasingly using the same tools. "The strategy works particularly well for business owners, executives, professionals, and athletes," he says. "People who have the income and credit profile to qualify, but who don't want to lock up massive amounts of capital." Take one instance that Smith portrays: a couple in their mid-50s earning $550,000 a year, with $5 million projected in retirement savings, all taxable. They want to double their projected retirement income to $40,000 per month tax-free. The traditional route would have required $25,000 per month in new savings. Instead, using premium financing and TFP's Legacy Plan™, they are able to commit just $25,000 per year, using collateral and lender capital to generate the same (or better) outcome. "That's a 12x difference in capital outlay," Smith emphasizes. "Same goal, dramatically different journey." Despite its advantages, premium financing has long been misunderstood, even within the financial advisory world. "A lot of advisors think it's too aggressive, too risky," Smith says. "But that's because they've never been properly educated on how the strategy works, or how the risk is managed. Once I walk them through the actual structure, their response is usually: 'Oh, this isn't nearly as risky as I thought.' And they're right." Smith points to several built-in safeguards: adjustable interest rates, liquidity buffers, collateral management, and carrier guarantees. "Like any financial tool, it has to be designed right. But the risks are far more manageable than most people believe." He adds that even major privately held insurance conglomerates are now leaning into premium financing. "They wouldn't even look at this space a few years ago. Now I'm one of their intermediaries, and they're fully behind it. This goes to show that, even the most conservative financial institutions are recognizing premium financing is an important planning opportunity. And is not as risky as once thought," Smith affirms. One of the most compelling aspects of the strategy is its tax advantage. If properly structured, both withdrawals and loans from the policy's cash value can be taken out tax-free, thanks to longstanding IRS rules protecting life insurance's unique status. "These aren't loopholes," Smith explains. "They're built into the tax code. The industry has powerful lobbying support because the products serve legitimate protection and planning needs. You're putting the money to work inside an IRS-recognized structure." Because of regulations passed in 1987, policies must adhere to specific funding limits, he agrees, but those limits still leave ample room for meaningful wealth growth. With higher tax rates on the horizon and more scrutiny on qualified retirement plans, Smith argues that professionals need smarter ways to diversify and preserve wealth. He states, "You spend your whole life building your business, your career, your income. Then retirement hits, and suddenly, you're giving a huge chunk of it away in taxes. Premium financing changes that trajectory." While the strategy isn't for everyone, health, age, and income requirements apply, Smith believes more advisors should be educating their clients. "This is advanced planning. It's what the best of the best are doing. And it's time more people knew about it."
Int'l Business Times
2 days ago
- Int'l Business Times
From Research to Real Life: Transforming the Opportunity for Early Detection of Alzheimer's Disease with i-Function
When healthcare entrepreneur Peter Kallestrup co-founded i-Function®, he set out with a clear mission: to take powerful innovations confined to academic research and make them widely accessible tools for real-world cognitive health improvements. "What if we could leverage all that incredible research being done in universities and make it available so that it can benefit people in the real world?" Kallestrup asked. That question became the foundation of a company designed not just to innovate, but to democratize access to cognitive care. i-Function ® is led by Kallestrup alongside two highly regarded academics, Dr. Philip D. Harvey , an expert in mental health and cognition, and Dr. Sarah J. Czaja , a leading authority in functional skills and aging research. Together, they have played a significant role in developing two flagship products: LASSI-D® and FUNSAT®. The former is a digital cognitive assessment tool; the latter, a digital functional skills assessment and training platform. While both serve different purposes, they both play a role in the process of assessing and supporting cognitive health. LASSI-D ™ is the company's most recent innovation, a 15-minute digital cognitive assessment designed to detect the earliest stages of Mild Cognitive Impairment (MCI) and asymptomatic older adults with preclinical Alzheimer's disease. Dr. Sara J. Czaja explains, "It's like a Cardiac Stress Test for the brain. In just 15 minutes, we can tell with high probability whether your cognitive aging is likely normal or whether something else might be going on." The test is completely self-guided, with a human avatar serving the role of a human testing technician, leading users through the process privately and comfortably on most smart devices. The value of early detection can't be overstated. According to research published in The Lancet , up to 40% of the risk of developing Alzheimer's can be mitigated through mid-late life lifestyle changes if the warning signs are caught early. "What would it be worth to have two more years with your mom, dad, or spouse with normal cognitive and functional abilities?" Dr. Harvey asks. "It's priceless. That's what we aim to offer, more time, more clarity, more hope." FUNSAT ™, the company's original product, addresses functional skills: the day-to-day tasks that many with cognitive impairments struggle to perform. From managing medications to using online banking or navigating a phone voice menu, the tool helps individuals regain or build these critical capabilities. "It's not just about remembering or understanding something, it's about utilizing those cognitive skills in real life," says Dr. Harvey. "If we identify someone with early MCI using LASSI-D™, then FUNSAT™ becomes one of the suggested practical next steps in helping people live independently for longer." While i-Function's tools have applications across many domains, clinical research, mental health treatment, rehabilitation, and aging care, their business model is currently B2B. Memory clinics, assisted living facilities, concierge medical practices, state mental health organizations, and pharma are among their key clients. "We are solving two problems," Kallestrup explains. "First, we give providers a fast, affordable, documented way to screen for early cognitive issues. Second, we offer an actionable path forward. That combination is rare." The company has already seen early traction. FUNSAT™ is being used in several state-run mental health facilities and in clinical trials, and LASSI-D™ has entered its first wave of clinical adoption. The rollout is ongoing, with strong interest from both specialists and academic research centers alike. "Doctors don't always have time or the appropriate tools to assess cognitive health thoroughly or early enough, and many aren't necessarily comfortable making this assessment independently," Kallestrup notes. "With LASSI-D, they can run a fast, highly accurate screening with instant results and recommendations while patients wait. That's powerful." Importantly, i-Function® is not focused on elite clinics or high-income users. "We are not building expensive tools for the wealthy," Peter Kallestrup, CEO of i-Function®, emphasizes. "This needs to be accessible to millions. Affordability is core to our mission." This ethos is one reason i-Function® in-licenses tools from leading research universities, then develops them into scalable, tech-enabled platforms. It's not about reinventing the science, it's about amplifying it. That model has also gathered serious attention. The company's research has been supported by several highly competitive NIH grants. "Everything we do is backed by peer-reviewed science," Kallestrup says. "We have had the privilege of presenting on national stages, and last year we were cited in the National Institute of Aging annual report. But the most important recognition is seeing how our tools can change lives." Looking ahead, i-Function® plans to continue to develop its current solutions as well as broaden its portfolio with new tools focused on the broad domain of cognitive health. The goal remains consistent: find transformative but underutilized academic discoveries and bring them to the people who need them most. For Kallestrup, it's a matter of urgency as much as innovation. "If you knew you were at risk of Alzheimer's, wouldn't you want to act now? Wouldn't you want the chance to intervene while it still matters?" he says. "That's the opportunity we are giving people. And we are just getting started."
Int'l Business Times
3 days ago
- Int'l Business Times
Dimov Tax's Playbook: Reporting Foreign Earnings Without Overpaying Uncle Sam
In an age where tax software promises instant refunds and automation tools threaten to replace advisors, George Dimov proves that personal attention, elite expertise, and proactive planning still matter—especially when taxes get complicated. Dimov is the founder and CEO of Dimov Tax, a fully remote CPA firm with reach across all 50 states and Canada. His client base includes high-earning professionals, freelance entrepreneurs, expatriates, and dual-state filers—individuals with incomes and investments that don't fit within the usual tax filing categories. His goal? To bring Big Four-level service to people who want responsive support, not a robot. With over 20 years of experience and a team of enrolled agents, tax attorneys, and a Canadian CPA, Dimov has carved out a niche as the go-to tax strategist for people with complex returns, and he's done it while scaling a remote-first company from the ground up. We recently sat down with Dimov to talk about how he built his firm, what high-earning professionals need to know, and why planning, especially for foreign and multi-state income, is the key to keeping more of what you earn. Finding Flexibility and a Market Gap Interviewer: George, you've built a firm that serves some of the most complex tax clients in the US. What initially motivated you to take the leap? George Dimov: "My goal in starting my business was that I was going to make the same amount at least as my regular job in order for me to have the flexibility to be able to spend time... and live a flexible and mostly remote‑based lifestyle." Dimov launched his firm with a clear benchmark: replace his $125K-plus salary before quitting his day job. It wasn't just about income; it was about testing demand, building cash reserves, and ensuring a smooth transition into a work-from-anywhere lifestyle that mirrors the lives of many of his clients. Interviewer: Was the market ready for you? Dimov: "There's such a shortage of accountants that as soon as I opened up my doors as an accountant... I was just packed from day until night." By recognizing accounting as an underserved profession, especially for people with multi-state, freelance, or international tax needs, Dimov captured a wave of unmet demand. Within weeks of opening, he had hired six employees and was operating out of a Midtown Manhattan office. It was a textbook case of what Dimov calls a "blue ocean opportunity," offering what others could not or would not. Building a Big-Four Skill Set with a Small-Firm Feel Interviewer: What sets Dimov Tax apart from traditional accounting firms? Dimov: "We have a Big Four accounting skill set in a small‑town firm environment and culture." That contrast is intentional. Dimov's firm combines technical precision, often found in national firms, with a boutique-level client experience. Clients aren't routed through call centers or ignored for weeks. Instead, they receive personalized attention with the same technical rigor they'd expect from a top-tier consultancy. Dimov: "People hire us and then expect things to be like AI... and we're just going to spit it out like a machine. But unfortunately, there's a human element." He's candid about the realities of tax work: It's not instant, and it shouldn't be. Good tax planning requires collaboration and critical thinking. Setting realistic expectations from the start helps Dimov build trust—and results—in a process that's more art than automation. The Power of Proactive Planning Interviewer: What's the most critical mindset shift you want your clients to adopt? Dimov: "The difference between tax preparation and tax planning is huge—tax planning has to be done proactively, rather than retroactively, and the best time to do tax planning is May, June, July." That window, after tax season but before year-end, is when clients can still make impactful decisions, such as funding retirement accounts, electing S-corp status, adjusting estimated payments, and more. Dimov's team works year-round to help clients fine-tune those moves for maximum savings. Interviewer: How do you get clients more engaged? Dimov: "Treat tax preparation and your tax advisor as a collaborative process—you're still responsible for your own taxes, so you do have to review and understand your returns." By treating clients as partners, not just customers, Dimov inspires financial literacy. He encourages clients to ask questions, check their drafts, and understand the strategies behind their filings. That transparency serves as both a safeguard and an opportunity for making smarter decisions. Relationship-Driven Growth Interviewer: What's your long-term vision for Dimov Tax? Dimov: "I want to have long-term relationships with happy clients that use us every year and refer all their friends and family to us." It's not just a marketing strategy—it's a business philosophy. For Dimov, sustainable growth comes from loyalty, not churn. His goal is to deliver such a high level of service that clients return year after year, bringing others with them. Interviewer: How do you manage deadlines and volume during the busy season? Dimov: "If you have your documents ready in February or March, hold your horses—there are 1,000 other people who paid for their returns a month ago, so we'll work in the order you came in." Dimov is firm about capacity planning. He avoids burnout by setting expectations early. Clients who plan are rewarded; those who delay are queued based on the order in which their submissions are received. It's a system built for fairness and quality control. Interviewer: One complaint people often have about accountants is communication. How do you address that? Dimov: "We have a one‑day response‑time requirement embedded in our company culture to ensure clients never get ghosted." In an industry where unanswered emails can stretch for weeks, that commitment stands out. Even in the off-season, Dimov's team responds within 24 hours. That responsiveness is especially critical for tech professionals, digital nomads, and business owners who can't afford delays. Serving the Complex and the Global Interviewer: Who do you serve best? Dimov: "I want to be the de facto firm that people use if they have a complex tax situation and are comfortable working online." His firm thrives in complexity, serving ex-pats, freelancers with multiple income streams, remote employees relocating mid-year, and families juggling equity compensation and rental properties. Dimov's cross-trained team excels at handling that complexity. Dimov: "My firm has EAs and tax attorneys across all 50 states—and a Canadian CPA, too—so we handle any US or cross‑border tax issue." This multidisciplinary structure means clients with foreign income, dual residencies, or multiple business entities don't have to consult separate experts. Everything's integrated under one roof. Negotiating Economic Cycles and Global Tax Codes Interviewer: You launched during a time of great uncertainty. How has that shaped your approach? Dimov: "Even during the 2008 crash, I wasn't affected—I hustled at small firms, and demand for accounting never wavered." Accounting, Dimov notes, is a recession-resilient field. Financial uncertainty often leads to increased demand for advisory services. That reliability gave him the confidence to go all in. Interviewer: What should American expats living abroad know before filing their taxes? Dimov: "As a US tax resident, you may be eligible to exclude up to $130,000 in foreign earned income for 2025 by filing Form 2555, provided you: Live and work in a foreign country. Pass either the Physical Presence Test (330 full days abroad in 12 months) or the Bona Fide Residence Test (a full calendar year of residency in another country)." Dimov explains that the Foreign Earned Income Exclusion (FEIE) only applies to active income, not to passive income, such as dividends or capital gains. But there's more. Dimov: "If you pay income tax to a foreign government, you can usually claim a foreign tax credit to reduce your US tax liability. This prevents double taxation on the same income." His team helps clients decide whether to use the exclusion, the credit, or both, depending on their situation. In high-cost cities, they may also qualify for a housing exclusion if their employer provides rent coverage. The Human Side of Tax Expertise George Dimov didn't build a tax firm that churns out generic returns. He engineered a firm for the overlooked: professionals with remote jobs, overlapping income streams, or complex equity comp. And he built it with a clear philosophy: serve well, communicate early and often, and plan. Learn more about George Dimov and his firm at or connect with him on LinkedIn at
